Patient Impact Award 2022 groep DRUP

DRUP trial wins Patient Impact Award 2022


This year’s Patient Impact Award, the Netherlands Cancer Institute’s annual prize for the most impactful clinical innovation, was awarded to the DRUP trial team. In this trial, patients with metastatic cancer who no longer have treatment options available to them, are treated with medicines that have already been on the market for other tumor types. Other countries are now following its innovative lead. Today, medical oncologist and researcher Emile Voest will accept the award.

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.